Clinical trial
Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation…
NCT00470834 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00470834 |
|---|---|
| Title | Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy |
| Official title | A Randomized Double-Blind Parallel Group Study Comparing Casodex (or Generic Equivalent) 50mg Plus Placebo to Casodex (or Generic Equivalent) 50mg Plus Dutasteride 3.5mg Administered for 18 Months to Men With Prostate Cancer Who Have Failed First-Line Androgen Deprivation Therapy (Assessed by Rising… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Neoplasms, Prostate |
| Intervention type | Drug |
| Interventions | dutasteride, placebo, bicalutamide |
| Enrollment | 127 |
| Start date | May 1, 2007 |
| Primary completion | Feb 1, 2013 |
| Completion | Feb 1, 2013 |
| First posted | May 8, 2007 |
| Last update posted | Feb 27, 2017 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: